ACRS earnings: a positive outcome, +6.5%

On November 4, 2020, Aclaris Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.5% in the window around the event. It had already run +14.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.